Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,084 INR | +0.40% | +4.20% | +26.82% |
06:09am | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines | MT |
Apr. 25 | Glenmark Lifesciences' Net Profit Slides in Fiscal Q4 | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 1,080.30 | 1,080.30 | 1,226.80 |
Spread/Res. | +0.25% | +0.25% | -11.72% |
Spread/Supp. | +10.12% | +20.54% | +28.45% |
Support | 983.45 | 898.45 | 843.10 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- GLENMARK Stock
- Charts Glenmark Pharmaceuticals Limited